GLP-1/glucagon dual agonistGLP-1 Agonists
Efinopegdutide
A PEGylated dual GLP-1 and glucagon receptor agonist by MSD/Hanmi. Phase 2 for obesity and NASH showed significant liver fat reduction. The glucagon activation differentiates it from pure GLP-1 agonists.
weight-lossGLP-1glucagonNASHPEGylated
3D Structure
3D Structure
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
No mass spec data
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A PEGylated dual GLP-1 and glucagon receptor agonist by MSD/Hanmi. Phase 2 for obesity and NASH showed significant liver fat reduction. The glucagon activation differentiates it from pure GLP-1 agonis…